Follow
Prof. GUIDO FRANCINI
Prof. GUIDO FRANCINI
Verified email at unisi.it
Title
Cited by
Cited by
Year
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
S Gill, CL Loprinzi, DJ Sargent, SD Thomé, SR Alberts, DG Haller, ...
Journal of clinical oncology 22 (10), 1797-1806, 2004
13122004
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients
DJ Sargent, RM Goldberg, SD Jacobson, JS Macdonald, R Labianca, ...
New England Journal of Medicine 345 (15), 1091-1097, 2001
11632001
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ...
Journal of Clinical Oncology 23 (34), 8664-8670, 2005
7782005
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials
D Sargent, A Sobrero, A Grothey, MJ O'Connell, M Buyse, T Andre, ...
Journal of Clinical Oncology 27 (6), 872, 2009
7182009
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia …
PF Conte, J Latreille, L Mauriac, F Calabresi, R Santos, D Campos, ...
Journal of Clinical Oncology 14 (9), 2552-2559, 1996
3261996
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
G Francini, R Petrioli, L Lorenzini, S Mancini, S Armenio, G Tanzini, ...
Gastroenterology 106 (4), 899-906, 1994
3171994
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the …
DJ Sargent, S Patiyil, G Yothers, DG Haller, R Gray, J Benedetti, M Buyse, ...
J Clin Oncol 25 (29), 4569-4574, 2007
2762007
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study
GF Mazzuoli, M Passeri, C Gennari, S Minisola, R Antonelli, C Valtorta, ...
Calcified tissue international 38, 3-8, 1986
2551986
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy
P Correale, MS Rotundo, MT Del Vecchio, C Remondo, C Migali, ...
Journal of immunotherapy 33 (4), 435-441, 2010
2492010
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin …
P Correale, MG Cusi, KY Tsang, MT Del Vecchio, S Marsili, ML Placa, ...
Journal of Clinical Oncology 23 (35), 8950-8958, 2005
2012005
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study
F Boccardo, A Rubagotti, A Perrotta, D Amoroso, M Balestrero, ...
Annals of oncology 5 (4), 337-342, 1994
1951994
Comparison between a cisplatin‐containing regimen and a carboplatin‐containing regimen for recurrent or metastatic bladder cancer patients: A randomized phase II study
R Petrioli, B Frediani, A Manganelli, G Barbanti, B De Capua, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1996
1921996
Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
R Petrioli, A Coratti, P Correale, C D’Aniello, L Grimaldi, G Tanzini, ...
American journal of clinical oncology 25 (5), 468-473, 2002
1312002
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine+ FOLFOX followed by subcutaneous granulocyte macrophage colony …
P Correale, P Tagliaferri, A Fioravanti, MT Del Vecchio, C Remondo, ...
Clinical Cancer Research 14 (13), 4192-4199, 2008
972008
Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A (*) 02.01 restricted, CEA‐peptide …
P Correale, A Aquino, A Giuliani, M Pellegrini, L Micheli, MG Cusi, ...
International journal of cancer 104 (4), 437-445, 2003
962003
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5 …
P Correale, MG Cusi, MT Del Vecchio, A Aquino, S Prete, KY Tsang, ...
The Journal of Immunology 175 (2), 820-828, 2005
942005
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
G Francini, R Petrioli, A Montagnani, A Cadirni, S Campagna, E Francini, ...
British journal of cancer 95 (2), 153-158, 2006
882006
Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: individual patient data from 12,915 patients on 15 randomized trials
DJ Sargent, S Wieand, J Benedetti, R Labianca, DG Haller, LE Shepherd, ...
Journal of Clinical Oncology 22 (14_suppl), 3502-3502, 2004
882004
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane
S Gonnelli, A Cadirni, C Caffarelli, R Petrioli, A Montagnani, MB Franci, ...
Bone 40 (1), 205-210, 2007
812007
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin
R Petrioli, A Pascucci, E Francini, S Marsili, A Sciandivasci, R Tassi, ...
Cancer chemotherapy and pharmacology 61, 105-111, 2008
792008
The system can't perform the operation now. Try again later.
Articles 1–20